Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001140361-22-017987
Filing Date
2022-05-06
Accepted
2022-05-06 06:09:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 PRER14A ny20004078x1_prer14a.htm PRER14A 5360183
2 logo_centerviewpartnersv2.jpg GRAPHIC 20936
3 logo_neogen.jpg GRAPHIC 30841
4 ny20004078x1_flowchart01.jpg GRAPHIC 70366
5 ny20004078x1_flowchart02.jpg GRAPHIC 108364
6 ny20004078x1_flowchart03.jpg GRAPHIC 111789
7 ny20004078x1_piechart01.jpg GRAPHIC 64155
8 ny20004078x1_piechart02.jpg GRAPHIC 47573
9 ny20004078x1_piechart03x1.jpg GRAPHIC 138769
10 ny20004078x1_piechart04x1.jpg GRAPHIC 170252
  Complete submission text file 0001140361-22-017987.txt   6410551
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: PRER14A | Act: 34 | File No.: 000-17988 | Film No.: 22898723
SIC: 2835 In Vitro & In Vivo Diagnostic Substances